Dune (NASDAQ:DUNE) announced this morning that it has filed a lawsuit in Delaware court alleging that its combination target TradeZero “fraudulently induced” it into entering the merger and has “materially breached” that agreement, causing “irreparable injury” to Dune. But, in a twist, it is also continuing to work to close the deal and intends to call a special meeting to vote on the transaction soon.
Several things are unusual about this situation starting with the fact that SPACs have been the target of litigation themselves, but rarely are they the plaintiffs of such suits. The act of a SPAC suing its target for fraud but still trying to complete the deal also appears at odds with itself. The suit asserts it is necessary to protect Dune and its investors, but if TradeZero misled it into a bad deal, then wouldn’t the best thing for investors be to terminate the deal rather than force it through?
A quick review of the conditions to termination filed in the Super 8-K shows Dune can terminate this combination if, among other things, “… by Dune if TradeZero’s audited combined financial statements materially deviate from its unaudited financial statements.” And while most of the public information on this suit has been heavily redacted and we don’t have access to the financials, “duping Dune” into this transaction with misleading financial information is at the heart of the allegations of this lawsuit. If the current allegations are true, it does seem like Dune would have cause to terminate.
Additionally, Dune and TradeZero have an outside date of July 12, 2022, which is just slightly longer than their current completion deadline of June 22, 2022. Which means they can’t just run out the clock to terminate without having to extend their deadline in order to find a new target. Plus, any extension would require a shareholder vote, which, unfortunately in today’s climate, would require an additional contribution of funds to trust. That can get expensive if a team needs a lot of additional time.
The choices are therefore threefold:
- Terminate the combination, extend and find a new target company
- Terminate the combination and liquidate the trust
- Put this to a shareholder vote and close or liquidate (if there’s a majority “no vote”)
But, in a liquidation, investor capital would be returned with interest and is therefore already protected in this case, and it would certainly appear to be better protected than if this deal were to close and be turned into shares of a company the SPAC now finds untrustworthy.
In the meantime, the slow tempo of the US legal process makes it likely that this litigation will be hanging over the deal though the vote unless it is summarily dismissed. And, that same speed may mean that investors and the public may not be privy to many details of the complaint until the deal is already done.
All told, this is a very unusual situation and if this deal does actually go to a vote, shareholders should be given all of the facts, no matter how ugly.
At the SPAC of Dawn SPACs have largely steered clear of the fintech sector, which used to be among its favorite hunting grounds of late, both due to unfavorable macro pressures and the lack of clear action on the traditional IPO side to comp to. That may soon change as buy-now-pay-later firm Klarna has confidentially...
At the SPAC of Dawn Stock market whip saws based on US government action are not likely going anywhere as President Donald Trump conceded “a little disturbance” is coming to the economy in a speech before a joint session of Congress. This pain in the short term is to be primarily the result of the...
Cal Redwood Acquisition Corp. has filed for a $200 million SPAC IPO, aiming to focus on opportunities in the TMT (Technology, Media, and Telecommunications) sector. The blank-check company intends to list on the Nasdaq under the symbol “CRAU”, offering 20,000,000 units at $10.00 each, with the trust funded at 100%. The unit structure includes a...
Relativity (NASDAQ:RACY) has entered into a definitive agreement to combine with wellness firm Instinct Brothers at a pro forma enterprise value of $242 million. Tokyo-based Instinct Brothers provides anti-aging treatments both through an in-person clinic and through consumer cosmetic products. The combined company is expected to trade on the Nasdaq under the symbol “BIOT” once...
At the SPAC of Dawn Presidents of both the New York and Richmond Fed are schedule to speak later today in what would have normally been routine remarks. But, the confluence of new 25% tariffs coming into effect against the US’ two largest trading partners and the Fed’s mood on inflation are likely to bring...